Marco Chacón, PhD

Marco Chacón, PhD

Marco Chacón, PhD

Assistant Vice President, Industry Alliances, University of Maryland, Baltimore

Dr. Marco A. Chacon is the Assistant Vice President of Industry Alliances in the Office of Research and Development at The University of Maryland, Baltimore.  As a seasoned biopharmaceutical executive and entrepreneur, Dr. Chacon works with the leadership team at UMB leading special projects to grow the BioPark tenant base and to strengthen the University’s research collaborations with industry.

Dr. Chacon is the Founder and Chairman of Paragon Bioservices, Inc., a Contract Development and GMP Manufacturing Organization (CDMO) located at the University of Maryland BioPark in Baltimore.  With ~ 200 employees and 75K square feet of space, Paragon specializes in the development and GMP manufacturing of Viral Vectors and Vaccines.

Dr. Chacon is also the Founder of IRAZU Biodiscovery, a Regenerative Medicine company seeking to develop therapeutic interventions to induce hypoxia tolerance and neuroprotection as described in experimental models of caloric restriction and hibernation, as well as during the neonatal period in mammals.

Dr. Chacon’s academic interests include control of metabolism, oxygen homeostasis and the regenerative potential of tissues and organs.

Dr. Chacon received a BS degree from Youngstown State University and a PH.D. Degree from The University of Maryland, College Park, MD.  He currently serves on the Board of Trustees of The UMB Foundation and was appointed in 2016 to The Life Sciences Advisory Board by Governor Lawrence J. Hogan.